Sana Bio's $150 Million IPO Expected to Provide Market Valuation of $10 Billion

Sana Biotechnology recently filed with the U.S. Securities and Exchange Commission (SEC) to launch an initial public offering (IPO) worth $150 million. But that number doesn’t quite reflect the company’s likely market valuation, which is expected to be between $9 billion and $12 billion.